Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 2
2004 3
2005 4
2020 4
2021 9
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
MRI tumour regression grade in locally recurrent rectal cancer.
Voogt ELK, Nordkamp S, van Zoggel DMGI, Daniëls-Gooszen AW, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Cnossen JS, van Lijnschoten G, Burger JWA, Rutten HJT, Nederend J. Voogt ELK, et al. BJS Open. 2022 May 2;6(3):zrac033. doi: 10.1093/bjsopen/zrac033. BJS Open. 2022. PMID: 35552373 Free PMC article.
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer.
Verrijssen AE, Dries WJF, Cnossen JS, Theuws J, Peulen HMU, van den Berg HA, Rijkaart DC, Voogt ELK, Kolkman-Deurloo IK, Nuyttens J, Rutten HJT, Burger JWA, Bimmel-Nagel CH. Verrijssen AE, et al. Among authors: voogt elk. J Contemp Brachytherapy. 2022 Aug;14(4):370-378. doi: 10.5114/jcb.2022.118305. Epub 2022 Jul 21. J Contemp Brachytherapy. 2022. PMID: 36199944 Free PMC article.
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).
van den Berg K, Schaap DP, Voogt ELK, Buffart TE, Verheul HMW, de Groot JWB, Verhoef C, Melenhorst J, Roodhart JML, de Wilt JHW, van Westreenen HL, Aalbers AGJ, van 't Veer M, Marijnen CAM, Vincent J, Simkens LHJ, Peters NAJB, Berbée M, Werter IM, Snaebjornsson P, Peulen HMU, van Lijnschoten IG, Roef MJ, Nieuwenhuijzen GAP, Bloemen JG, Willems JMWE, Creemers GJM, Nederend J, Rutten HJT, Burger JWA. van den Berg K, et al. Among authors: voogt elk. BMC Cancer. 2022 Sep 6;22(1):957. doi: 10.1186/s12885-022-09947-w. BMC Cancer. 2022. PMID: 36068495 Free PMC article.
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer.
van Zoggel DMGI, Voogt ELK, van Lijnschoten IG, Cnossen JS, Creemers GJ, Nederend J, Bloemen JG, Nieuwenhuijzen GAP, Burger PJWA, Lardenoije SGGF, Rutten HJT, Roef MJ. van Zoggel DMGI, et al. Among authors: voogt elk. Colorectal Dis. 2022 Jan;24(1):59-67. doi: 10.1111/codi.15934. Epub 2021 Nov 16. Colorectal Dis. 2022. PMID: 34601782
Reply to: Use of induction chemotherapy in locally advanced rectal cancers to increase the response rates: Is it actually helping?
Voogt ELK, Schaap DP, van den Berg K, Nieuwenhuijzen GAP, Bloemen JG, Creemers GJ, Willems J, Cnossen JS, Peulen HMU, Nederend J, van Lijnschoten G, Burger JWA, Rutten HJT. Voogt ELK, et al. Eur J Surg Oncol. 2021 Sep;47(9):2473-2474. doi: 10.1016/j.ejso.2021.06.021. Epub 2021 Jun 24. Eur J Surg Oncol. 2021. PMID: 34210580 No abstract available.
26 results